Loading data for XBIT — first visit, this takes a few seconds.

알림

XBiotech Inc. (XBIT)

NasdaqGS: XBIT · 실시간 가격 · USD

2.27

-0.03 (-1.30%)

종가 기준: Aug 28, 2026, 3:57 PM

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

-1.30% (1D)

매수호가	1.67
시가총액	69.21M
매출 (ttm)	n/a
순이익 (ttm)	-45.13M
	0.85
	-1.48
	n/a
	17.46
P/B (ttm)	0.54
P/S (ttm)	n/a
실적 발표일	May 11, 2020

매도호가	2.96
거래량	6,960
평균 거래량 (20일)	34,053
시가	2.32
전일 종가	2.30
일중 범위	2.26 - 2.32
52주 범위	2.09 - 3.44
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	2021년 7월 15일

XBIT 소개

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malai...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Apr 15, 2015

직원 수 87

상장 거래소 NasdaqGS

티커 XBIT

웹사이트 https://www.xbiotech.com

전체 기업 정보

재무 실적

2025년 XBiotech의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -45.54M로, 18.19% 증가했습니다.

재무제표

어닝 서프라이즈

XBiotech가 Mar 16, 2020에 분기 실적을 발표했습니다:

매출 $0 예상치 하회 $0, 및 NaN% 전년 대비 성장.
EPS -0.28 예상치 하회 -0.13, 및 45.10% 전년 대비 성장.

다음 실적 발표

XBiotech Inc.의 실적 발표 예정일은 May 11, 2020, 장 마감 후입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

5개월 전 · Associated Press Finance

XBiotech: Q4 Earnings Snapshot

AUSTIN, Texas (AP) — XBiotech Inc. XBIT) on Friday reported a loss of $26.9 million in its fourth quarter. On a per-share basis, the Austin, Texas-based company said it had a loss of 88 cents.

8개월 전 · Simply Wall St.

3 Promising Penny Stocks With Market Caps Over $30M

Major stock indexes in the United States have recently experienced a surge, driven by gains in technology shares and positive economic indicators. While the term "penny stocks" might seem outdated, it...

9개월 전 · Simply Wall St.

November 2025's Promising Penny Stocks To Watch

As the Dow Jones Industrial Average reaches an all-time high amid optimism over the potential end of a prolonged U.S. government shutdown, investors are keenly observing market dynamics and seeking op...

9개월 전 · Associated Press Finance

XBiotech: Q3 Earnings Snapshot

AUSTIN, Texas (AP) — XBiotech Inc. XBIT) on Wednesday reported a loss of $6 million in its third quarter. The Austin, Texas-based company said it had a loss of 20 cents per share.

1년 전 · Simply Wall St.

XBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 52% stake, while 36% is held by insiders

Key Insights Significant control over XBiotech by retail investors implies that the general public has more power to...

XBiotech Inc. (XBIT)